Delivery Order SPE2DB24D1201-SPE2DB25FJDBE
- Not listed
- The Defense Logistics Agency awarded a $8,378.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. The contract, which is unset-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). Performance of this delivery order will be completed by June 18, 2025, with fulfillment occurring at the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency (DLA) awarded a $1,632.54 delivery order contract to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $3,444.33 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pens with a completion date of August 27, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $19,436.83 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens. This non-set-aside contract is scheduled for completion by September 17, 2025, and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,979.98 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, issued under a non-competitive, non-set-aside procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDBEDelivery Order
The Defense Logistics Agency awarded a $2,176.72 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens. This firm fixed price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order was competitively awarded without set-aside designation and will be fulfilled at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through its comprehensive DLA contract vehicle, the company supplies a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order represents routine pharmaceutical fulfillment under the larger prime vendor agreement that enables AmerisourceBergen to support the Defense Health Agency and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/11/25 |